Abstract
Direct activation of human cytotoxic T lymphocytes (CTL) by interleukin (IL)‐18 was observed in a system in which CTL effective against autologous tumor cells were generated. Peripheral blood mononuclear cells (PBMC) from tumor‐bearing patients, after removal of natural killer (NK) cells, were cultured in a medium containing IL‐1, ‐2, ‐4, and ‐6, with or without IL‐18, and stimulated with autologous tumor cells. IL‐18 increased the activity of the CTL and the proportion of autologous CD8+ T cells present after 28 days in the induction culture. When purified CD8+ T cells were cultured in the presence of IL‐18 and IL‐2 for 7 days, the CTL showed enhanced cytotoxic activity against autologous tumor cells. Moreover, a purified CD8+ T cell population, which did not exhibit any apparent cytotoxic activity against autologous tumor cells, displayed cytotoxic activity after 7‐day incubation with IL‐18. These results suggest that IL‐18 may be useful to generate autologous CTL in humans and may thereby contribute to adoptive immunotherapy for tumors.
Keywords: IL‐18, Cytotoxic T lymphocytes, Adoptive immunotherapy
Full Text
The Full Text of this article is available as a PDF (92.8 KB).
REFERENCES
- 1. ) Yamasaki , T. , Handa , H. , Yamashita , J. , Watanabe , Y. , Namba , Y. and Hanaoka , M.Specific adoptive immunotherapy with tumor‐specific cytotoxic T‐lymphocyte clone for murine malignant gliomas . Cancer Res. , 44 , 1776 – 1783 ( 1984. ). [PubMed] [Google Scholar]
- 2. ) Rosenberg , S. A. , Lotze , M. , Muul , T. L. , Leitman , M. S. , Chang , A. E. , Ettinghausen , E. S. , Matory , E. Y. , Skibber , J. M. , Shiloni , E. and Vetto , J.Observation on the systemic administration of autologous lymphokine‐activated killer cells and recombinant interleukin‐2 to patients with metastatic cancer . N. Engl. J. Med. , 313 , 1485 – 1492 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Muul , L. M. , Spiess , P. J. , Director , E. P. and Rosenberg , S. A.Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma . J. Immunol. , 138 , 989 – 995 ( 1987. ). [PubMed] [Google Scholar]
- 4. ) Topalian , S. L. , Muul , L. M. , Solomon , D. and Rosenberg , S. A.Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials . J. Immunol. Methods , 102 , 127 – 141 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Topalian , S. L. , Solomon , D. and Rosenberg , S. A.Tumorspecific cytolysis by lymphocytes infiltrating human melanomas . J. Immunol. , 142 , 3714 – 3725 ( 1989. ). [PubMed] [Google Scholar]
- 6. ) Nakashima , M. , Watanabe , T. , Koprowski , H. , Schuchter , L. and Steplewski , Z.In vitro expansion of tumor‐specific, HLA‐restricted human CD8+ cytolytic T lymphocytes . Cell. Immunol. , 155 , 53 – 61 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Liu , S. Q. , Shiba , R. , Kim , B. S. , Saijo , K. and Ohno , T.Long‐term serum/plasma‐free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells . Cancer Immunol. Immunother. , 39 , 279 – 285 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Liu , S. Q. , Shiraiwa , H. , Kawai , K. , Hayashi , H. , Akaza , H. , Kim , B. S. , Oki , A. , Nishida , M. , Kubo , T. , Hashizaki , K. , Saijo , K. and Ohno , T.Tumor‐specific autologous cytotoxic T lymphocytes from tissue sections . Nat. Med. , 2 , 1283 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Tsurushima , H. , Liu , S. Q. , Tsuboi , K. , Yoshii , Y. , Nose , T. and Ohno , T.Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme . J. Neurosurg. , 84 , 258 – 263 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Okumura , H. , Tsutsui , H. , Komatsu , T. , Yutsudo , M. , Hakura , A. , Tanimoto , T. , Torigoe , K. , Okura , T. , Nukada , Y. , Hattori , K. , Akita , K. , Namba , M. , Tanabe , F. , Konishi , K. , Fukuda , S. and Kurimoto , M.Cloning of new cytokine that induces IFN‐γ production by T cells . Nature , 378 , 88 – 91 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Ushio , S. , Namba , M. , Okura , T. , Hattori , K. , Nukada , Y. , Akita , K. , Tanabe , F. , Konishi , K. , Micallef , M. , Hujii , M. , Torigoe , K. , Tanimoto , T. , Fukuda , S. , Ikeda , M. , Okamura , H. and Kurimoto , M.Cloning of the cDNA for human IFN‐γ‐inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein . J. Immunol. , 156 , 4274 – 4279 ( 1996. ). [PubMed] [Google Scholar]
- 12. ) Zhang , T. , Kawakami , K. , Qureshi , M. H. , Okamura , H. , Kurimoto , M. and Saito , A.Interleukin‐12 (IL‐12) and IL‐18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells . Infect. Immun. , 65 , 3594 – 3599 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. ) Dao , T. , Ohashi , K. , Kayano , T. , Kurimoto , M. and Okumura , H.Interferon‐γ‐inducing factor, a novel cytokine, enhances Fas ligand‐mediated cytotoxicity of murine T helper 1 cells . Cell. Immunol. , 173 , 230 – 235 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Tsutui , H. , Nakanishi , K. , Matsui , K. , Higashino , K. , Okumura , H. , Miyazawa , Y. and Kaneda , K.IFN‐γ‐inducing factor up‐regulates Fas ligand‐mediated cytotoxic activity of murine natural killer cell clones . J. Immunol. , 157 , 3967 – 3973 ( 1996. ). [PubMed] [Google Scholar]
- 15. ) Kawai , K. , Sasaki , T. , Saijo , K. K. , Akaza , H. , Koiso , K. and Ohno , T.Additive effects of antitumor drugs and lymphokine‐activated killer cell cytotoxic activity in tumor cell killing determined by lactate dehydrogenase‐release assay . Cancer Immunol. Immunother. , 35 , 225 – 229 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Liu , S. Q. , Saijo , K. , Todoroki , T. and Ohno , T.Induction of human autologous cytotoxic T lymphocytes on formalin‐fixed and paraffin‐embedded tumour sections . Nat. Med. , 1 , 267 – 271 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Micallef , M. J. , Tanimoto , T. , Kohno , K. , Ikeda , M. and Kurimoto , M.Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma . Cancer Res. , 57 , 4557 – 4563 ( 1997. ). [PubMed] [Google Scholar]
- 18. ) Halverson , D. C. , Schwartz , G. N. , Carter , C. , Gress , R. E. and Fowler , D. H.In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype . Blood , 90 , 2089 – 2096 ( 1997. ). [PubMed] [Google Scholar]
- 19. ) Chouaib , S. , Chehimi , J. , Bani , L. , Genetet , N. , Tursz , T. , Gay , F. , Trinchieri , G. and Mami , C. F.Interleukin 12 induces the differentiation of major histocompatibility complex class I‐primed cytotoxic T‐lymphocyte precursors into allospecific cytotoxic effectors . Proc. Natl. Acad. Sci. USA , 91 , 12659 – 12663 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. ) Kobayashi , M. , Fitz , L. , Ryan , M. , Hewick , R. M. , Clark , S. C. , Chan , S. , Loudon , R. , Sherman , F. , Perussia , B. and Trinchieri , G.Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes . J. Exp. Med. , 170 , 827 – 845 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. ) Wolf , S. F. , Temple , P. A. , Kobayashi , M. , Young , D. , Dicig , M. , Lowe , L. , Dzialo , R. , Fitz , L. , Ferenz , C. , Hewick , R. M. , Kelleher , K. , Herrmann , S. , Clark , H. C. , Azzoni , S. L. , Chan , H. , Trinchieri , S. G. and Perussia , B.Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells . J. Immunol. , 146 , 3074 – 3081 ( 1991. ). [PubMed] [Google Scholar]
- 22. ) Torigoe , K. , Ushio , S. , Okura , T. , Kobayashi , S. , Taniai , M. , Kunikata , T. , Murakami , T. , Sanou , O. , Kojima , H. , Fujii , M. , Ohta , T. , Ikeda , M. , Ikegami , H. and Kurimoto , M.Purification and characterization of the human interleukin‐18 receptor . J. Biol. Chem. , 272 , 25737 – 25742 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 23. ) Roth , J. A. , Osborne , B. A. and Ames , R. S.Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma‐derived immunosuppressive factor expressing HLA‐DR and immunoglobulin‐related determinants . J. Immunol. , 130 , 303 – 308 ( 1983. ). [PubMed] [Google Scholar]
- 24. ) Siegel , J. P.Effects of interferon‐gamma on the activation of human T lymphocytes . Cell. Immunol. , 111 , 461 – 472 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 25. ) Maraskovsky , E. , Chen , W. F. and Shortman , K.IL‐2 and IFN‐gamma are two necessary lymphokines in the development of cytolytic T cells . J. Immunol. , 143 , 1210 – 1214 ( 1989. ). [PubMed] [Google Scholar]